⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockAustraliaNasdaqGS

TLX

Telix Pharmaceuticals Limited

Healthcare · Biotechnology

9.15USD

-0.3900 (-4.09%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on TLX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End12/2025 Q4
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 9.15
P/E91.5
Dvd Ind Yld0.0%
P/B7.46
P/S3.9
Curr EV/T12M EBITDA49.2
Mkt Cap (USD)3.1B
Curr EV (USD)3.4B
2)

Per Share Data

EPS T12M-0.02
DPS—
Bk Val Per Sh1.44
Rev/Sh2.48
Cash/Sh0.74
Curr Shares Out338.8M
FCF/Sh-0.19
3)

Cash Flow Analysis

P/CF-258.2
Curr P/FCF-50.8
CF/NI1.7
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-1.5%
Eff Interest Rate19.8%
4)

Growth Potential

Dil EPS 1Y Gr-121.6%
Cap 1Y Gr16.1%
BPS 1Y Gr25.5%
R&D To Sales21.3%
Retention Rate100.0%
Rev 1Y Gr55.6%
FCF 1Y Gr-1250.9%
Assets 1Y Gr23.8%
5)

Profitability

EBITDA0.1B
EBIT0.0B
Operating Margin2.2%
Pretax Margin-0.7%
Net Margin-0.9%
ROA-0.7%
ROE-3.0%
ROC—
Asset Turnover0.76
6)

Structure

Current Ratio1.43
Quick Ratio1.74
Debt/Assets34.8%
Debt/Com Eq97.5%
Net Debt/EBITDA3.77
Tot Debt/Capital49.4%
Gross Margin53.1%
EBIT/Int Exp0.4

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.